PHT 776
Alternative Names: HBP 143; HPB-143; PHT-776Latest Information Update: 31 Mar 2025
At a glance
- Originator Polymed Biopharmaceuticals
- Class Anti-inflammatories; Small molecules
- Mechanism of Action IRAK4 protein degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Atopic dermatitis; Hidradenitis suppurativa